ICICI Prudential Nifty Pharma Index Fund
- NAV
- ₹21.00
- —30 Oct 2026
- AUM (₹ Cr)
- 151
- Average, July - September 2026
- Expense ratio
- 0.51%
- Regular 1.13%
- Risk
- Very High
- SEBI riskometer
- 1Y return
- 21.8%+2.0%
- Benchmark 19.8%
- 3Y CAGR
- 22.5%-0.1%
- Benchmark 22.7%
- 5Y CAGR
- —
- Category 9.8%
Rank in category
Too young for a combined rank, which needs five years. On its 1-year return it is #2 of 155.
Ranked on 1Y, 3Y and 5Y together. 33 of 216 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily NAVs. Risk-free rate 6.5% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +2.6% | +2.2% | +16.7% | +19.6% | +21.8% | +22.5% | — | — | +21.3% |
| Nifty Pharma TRI | — | — | — | — | 19.8% | 22.7% | — | — | 21.6% |
| Index: Sector & Thematic average | 0.0% | -5.1% | -0.5% | -4.7% | -4.4% | 11.0% | 9.8% | 11.0% | 3.6% |
| Difference | — | — | — | — | +2.0% | -0.1% | — | — | -0.3% |
Portfolio
Valuation
- P/E
- 42.4
- 86% above its category
- Category median
- 22.8
- 171 Index: Sector & Thematic funds
- Benchmark P/E
- 42.7
- Nifty Pharma
P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 16 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.
Fund details
- Fund house
- ICICI Prudential Mutual Fund
- Category
- Equity · Index: Sector & Thematic
- SEBI classification
- Other / Index Funds ETFs
- Benchmark
- Nifty Pharma TRI
- Launch date
- 15 Dec 2022 (3.9 years)
- Structure
- Open Ended · Index
- Plans and options
- Direct Growth, Regular Growth
- Fund manager
- Nishit Patel
- Minimum SIP
- ₹1,000
- Minimum lumpsum
- ₹1,000 (then ₹1,000)
- Exit load
- None
- Lock-in
- None
- Riskometer
- Very High (benchmark Very High)
- Expense ratio as of
- 28 Oct 2026
- AUM period
- July - September 2026
- ISIN, Direct Growth
- INF109KC11M9
- ISIN, Regular Growth
- INF109KC18L6
- Scheme code
- 150930, 150929
NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.
Other index: sector & thematic funds
Other funds in the Index: Sector & Thematic category.
- HDFC Nifty Auto Index FundHDFC Mutual Fund · ₹151 Cr · ER 0.97%
- Groww BSE Hospitals ETFGroww Mutual Fund · ₹137 Cr · ER 0.55%
- Tata Nifty500 Multicap India Manufacturing 50:30:20 Index FundTata Mutual Fund · ₹137 Cr · ER 0.58%
- ICICI Prudential Nifty PSU Bank ETFICICI Prudential Mutual Fund · ₹131 Cr · ER 0.41%
- Axis Nifty IT Index FundAxis Mutual Fund · ₹130 Cr · ER 0.43%
- ICICI Prudential Nifty Commodities ETFICICI Prudential Mutual Fund · ₹128 Cr · ER 0.35%